This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Novel Antipsychotic Use in Schizophrenia

 

Published: August 31, 2000

Article Abstract

It is now 100 years since the conceptof dementia praecox was first proposedby Kraepelin and then renamedschizophrenia by Bleuler. In his laterwritings, Kraepelin made it clear thathe regarded it as a provisional category.Sadly, we are still stuck withthis provisional category, said ProfessorRobin Murray in his presentation.

Volume: 61

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...